Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of David Rodman
Introduction
David Rodman is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide compositions. With a total of three patents to his name, Rodman's work focuses on innovative methods for treating cancer.
Latest Patents
Rodman's latest patents include groundbreaking inventions related to oligonucleotide inhibitors of miR-155. These inventions provide methods for treating cancers, such as T cell lymphoma, by administering oligonucleotide inhibitors. The patents also detail methods for reducing or inhibiting the proliferation of malignant T cells, showcasing the potential impact of his work on cancer treatment.
Career Highlights
David Rodman is currently associated with Miragen Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in oligonucleotide compositions has positioned him as a key player in the biotechnology sector.
Collaborations
Rodman collaborates with talented professionals in his field, including Anita Seto and Christina Marie Dalby. These collaborations enhance the innovative potential of his projects and contribute to the advancement of cancer therapies.
Conclusion
David Rodman's contributions to biotechnology, particularly in cancer treatment, highlight his role as an influential inventor. His patents and ongoing work at Miragen Therapeutics, Inc. reflect his commitment to advancing medical science.